|
SPTLC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12799999999014E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75131999999856E-05 |
| Normal-vs-Stage2 |
7.092100E-02 |
| Normal-vs-Stage3 |
1.572420E-01 |
| Normal-vs-Stage4 |
9.300500E-03 |
| Stage1-vs-Stage2 |
7.406200E-01 |
| Stage1-vs-Stage3 |
5.787600E-01 |
| Stage1-vs-Stage4 |
4.888600E-01 |
| Stage2-vs-Stage3 |
8.403600E-01 |
| Stage2-vs-Stage4 |
4.224000E-01 |
| Stage3-vs-Stage4 |
4.121400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.47810000000893E-05 |
| Normal-vs-AfricanAmerican |
9.73800000000358E-05 |
| Normal-vs-Asian |
6.570600E-04 |
| Caucasian-vs-AfricanAmerican |
4.471000E-01 |
| Caucasian-vs-Asian |
4.633600E-01 |
| AfricanAmerican-vs-Asian |
5.288400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28610000047236E-07 |
| Normal-vs-Female |
2.395400E-01 |
| Male-vs-Female |
1.838030E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.55190000000039E-05 |
| Normal-vs-Extreme_Weight |
1.66744999999802E-05 |
| Normal-vs-Obese |
8.232500E-02 |
| Normal-vs-Extreme_Obese |
2.159700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.497800E-01 |
| Normal_Weight-vs-Obese |
7.176100E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.104000E-01 |
| Extreme_Weight-vs-Obese |
6.295500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.947000E-01 |
| Obese-vs-Extreme_Obese |
3.069400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.242200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.584100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.57380000540297E-08 |
| Normal-vs-Age(81-100Yrs) |
1.18680000005256E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.777600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.077000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.809700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.002700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.261800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.582600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.556100E-04 |
| Normal-VS-Type2 PRCC |
4.1293000130338E-09 |
| Normal-VS-KIRP CIMP |
6.761400E-01 |
| Normal-VS-Unclassified PRCC |
6.350600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.117820E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.555700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.602200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.649900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.975200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.013400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36929999999358E-05 |
| Normal-vs-N1 |
7.286300E-02 |
| Normal-vs-N2 |
2.578600E-01 |
| N0-vs-N1 |
2.739800E-01 |
| N0-vs-N2 |
9.356000E-01 |
| N1-vs-N2 |
6.008000E-01 |
|
|
